Noticias de RXRX_US

Noticias del mercado

Últimas noticias sobre RXRX_US — 174 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RXRX_US ✕ 174 resultados
24/04/2026 RXRX_US — TradingKey ES ← EN
RXRX|Recursion Pharmaceuticals Inc|Precio:3.510|Cambio%:0.01

RXRX|Recursion Pharmaceuticals Inc|Price:3.510|Chg%:0.01

24/04/2026 RXRX_US — Sahm
AI-Driven Target Discovery Breakthrough Might Change The Case For Investing In Recursion Pharmaceuticals (RXRX)
23/04/2026 RXRX_US — Yahoo Finance
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market

Recursion Pharmaceuticals (RXRX) alcanzó los 3,5 dólares al cierre del último día de negociación, lo que refleja un cambio del -6,17% en comparación con su último cierre.

22/04/2026 RXRX_US — HarianBasis.co ES ← EN
Recursion Pharmaceuticals utiliza IA para acelerar el desarrollo de fármacos

Recursion Pharmaceuticals Uses AI to Accelerate Drug Development

22/04/2026 RXRX_US — Insider Monkey ES ← EN
Recursion Pharmaceuticals Inc (RXRX): ¿Está funcionando la estrategia de IA?
22/04/2026 RXRX_US — Insider Monkey ES ← EN
Recursion Pharmaceuticals Inc (RXRX): ¿Está funcionando la estrategia de IA?

Recursion Pharmaceuticals Inc (RXRX): Is AI Strategy Working?

22/04/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals Inc (RXRX): Is AI Strategy Working?
22/04/2026 RXRX_US — Stock Titan
Christopher Gibson sells Class A shares (NASDAQ: RXRX) in four filings
22/04/2026 RXRX_US — Sahm
Assessing Recursion Pharmaceuticals (RXRX) Valuation After AI Webcast Highlights Drug Target Breakthrough
22/04/2026 RXRX_US — MarketBeat ES ← EN
Formulario 10K de Recursion Pharmaceuticals (RXRX) y últimas presentaciones ante la SEC 2026

Recursion Pharmaceuticals (RXRX) 10K Form and Latest SEC Filings 2026

21/04/2026 RXRX_US — MSN ES ← EN
Recursion Pharmaceuticals Inc. (RXRX) se asocia con Citeline para desarrollar una plataforma ClinTech impulsada por IA

Recursion Pharmaceuticals Inc. (RXRX) partners with Citeline to develop AI-powered ClinTech platform

21/04/2026 RXRX_US — MarketBeat
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Given Consensus Recommendation of "Hold" by Analysts
20/04/2026 RXRX_US — laocai.gov.vn ES ← EN
Por qué las acciones de Recursion Pharmaceuticals (RXRX) podrían caer (ligera caída) 2026-04-20 - Señales de impulso social

Why Recursion Pharmaceuticals (RXRX) Stock Could Fall (Slight Dip) 2026-04-20 - Social Momentum Signals

19/04/2026 RXRX_US — Yahoo Finance
Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership
17/04/2026 RXRX_US — Sahm
Is Recursion Pharmaceuticals (RXRX) Turning Conference Spotlights Into a Durable AI Drug Discovery Edge?
17/04/2026 RXRX_US — MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 1,244,833 Shares of Recursion Pharmaceuticals, Inc. $RXRX
16/04/2026 RXRX_US — simplywall.st
Is Recursion Pharmaceuticals (RXRX) Turning Conference Spotlights Into a Durable AI Drug Discovery Edge?
16/04/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note
10/04/2026 RXRX_US — Sahm ES ← EN
Por qué la recursión (RXRX) ha aumentado un 10,8% después de profundizar la asociación con Citeline para impulsar ensayos clínicos impulsados ​​por IA
09/04/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors

Página 6 de 9

keyboard_arrow_up